The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 8

More JCP Articles

JCP
Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD
Podcast

Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD

February 10, 2026

Dr. Halassa shares clinical insights on xanomeline-trospium for inpatient schizophrenia, addressing negative symptoms and treatment-resistant cases.
,
JCP
Latency to LAI Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia
Original Research

Latency to LAI Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia

February 9, 2026

Although delayed initiation was linked to better treatment adherence, early LAI use reduced hospitalization in first-episode patients.
,
JCP
Dissociative Subtype of PTSD in US Military Veterans
Brief Report

Dissociative Subtype of PTSD in US Military Veterans

February 4, 2026

Of 169 veterans who screened positive for past-month PTSD, 87 screened positive for the dissociative subtype of PTSD.
, , , et al
JCP
Unwanted Intrusive Thoughts of Infant-Related Sexual Harm
Original Research

Unwanted Intrusive Thoughts of Infant-Related Sexual Harm

February 4, 2026

Unwanted intrusive thoughts (UITs) of infant-related sexual harm were reported by 9.2% of participants. There was no association between these UITs and sexual behavior toward one’s infant.
, , , et al
JCP
Rationale for Clozapine Trial
Letter to the Editor

Rationale for Clozapine Trial

January 28, 2026

Dr Mattes comments on a recent article examining the use of clozapine versus other antipsychotic options.
JCP
Factors Associated with Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents
Original Research

Factors Associated with Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents

January 28, 2026

Within 6 months of the initial emergency department (ED) visit, 21.7% of patients who initially attended the ED for self-injurious thoughts and behaviors returned for the same reason.
, , , et al
JCP
The Position of Clozapine in Patients with Treatment-Resistant Schizophrenia: Reply to Mattes
Letter to the Editor

The Position of Clozapine in Patients with Treatment-Resistant Schizophrenia: Reply to Mattes

January 28, 2026

Dr Andrade replies to a letter about his article on factors affecting choice of clozapine versus other antipsychotics.
JCP
Developing Algorithmic Psychiatry with Michael Halassa MD, PhD
Podcast

Developing Algorithmic Psychiatry with Michael Halassa MD, PhD

January 27, 2026

,
JCP
Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?
ASCP Corner

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

January 26, 2026

This article will familiarize US clinicians with amisulpride’s history and data, and the rationale behind development of LB-102, an N-methylated analogue of amisulpride.
,
JCP
Urological Commentary on Ketamine-Associated Uropathy
Letter to the Editor

Urological Commentary on Ketamine-Associated Uropathy

January 26, 2026

The author comments on a recent article reviewing ketamine-associated uropathy in therapeutic and nontherapeutic settings.
JCP
Ketamine-Associated Uropathy in Therapeutic Contexts: Reply to Abdelrahman
Letter to the Editor

Ketamine-Associated Uropathy in Therapeutic Contexts: Reply to Abdelrahman

January 26, 2026

Dr Andrade responds to a letter commenting on his recent review of ketamine-associated uropathy in therapeutic and nontherapeutic settings.
JCP
Next-Step Treatment Options for Treatment-Resistant Depression
Consensus Statement

Next-Step Treatment Options for Treatment-Resistant Depression

January 21, 2026

Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe